FindTrial
Sign In

Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms

Fecal Microbiota Transplantation for Decolonization of Multidrug-resistant Microorganisms: Randomized Double Blinded Study

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07265817
Enrollment
60
Registered
2025-12-05
Start date
2025-12-01
Completion date
2027-10-01
Last updated
2025-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carbapenem-Resistant Enterobacteriaceae Colonization

Brief summary

The aim of the study is to see whether fecal microbiota transplantation is effective to decolonize multidrug-resistant organisms.

Interventions

COMBINATION_PRODUCTFecal Microbial transplant Capsules

3 pills per day for 3 consecutive days with placebo comparatator

COMBINATION_PRODUCTPlacebo

The same amount and shape capsules

Sponsors

Kyungpook National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
19 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients who have positive results in PCR or culture of rectal swab.

Exclusion criteria

* Not provide a consent.

Design outcomes

Primary

MeasureTime frame
Conversion to negative organism1 year

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026